Suppr超能文献

移植后免疫抑制治疗对胃肠转运的生物磁学方法影响:一项初步研究。

Influence of post-transplant immunosuppressive therapy on gastrointestinal transit using biomagnetic method: a pilot study.

作者信息

Teixeira Maria do Carmo B, Américo Madileine F, Oliveira Ricardo B, Miranda José Ricardo A, Romeiro Fernando G, Corá Luciana A

机构信息

Centro de Ciências da Saúde, Universidade Estadual de Ciências da Saúde de Alagoas - UNCISAL, Dr Jorge Lima, 113, 57010-382, Maceió, AL, Brazil,

出版信息

Dig Dis Sci. 2015 Jan;60(1):174-80. doi: 10.1007/s10620-014-3335-8. Epub 2014 Aug 22.

Abstract

BACKGROUND

Immunosuppressive therapy after kidney transplant is necessary to prevent allograft rejection and it is the cause of several gastrointestinal (GI) disorders that have been scantily studied.

OBJECTIVES

This study was aimed at investigating the influence of triple immunosuppressive therapy on GI transit in renal transplant patients by employing a biomagnetic technique.

METHODS

Twenty-one renal transplant patients underwent triple therapy, which included either tacrolimus (TAC) or cyclosporin A (CsA) associated with prednisone and azathioprine. They were all evaluated, and fifteen other healthy individuals formed the control group. After a standardized meal, GI transit of magnetic markers was assessed using Alternating Current Biosusceptometry (ACB).

RESULTS

Patients taking TAC had significantly accelerated gastric emptying and colonic arrival (p ≤ 0.001) when compared with those taking CsA and those in the control group. However, no differences were observed in small bowel transit among the groups studied. Overall, the inter-subject coefficients of variation for gastrointestinal transit parameters were higher for the TAC group and similar for the CsA and control groups.

CONCLUSION

This study demonstrated that ACB is a suitable methodology when evaluating the influence of different immunosuppressive therapies on gastrointestinal transit after renal transplantation. Pronounced inter-individual variation was found in patients treated with tacrolimus, thus showing the prokinetic effect of this drug on GI motility. Studies of motility patterns in this population could be useful as complementary information toward determining the mechanisms and the relationship between motility and therapeutic doses.

摘要

背景

肾移植后进行免疫抑制治疗对于预防同种异体移植排斥反应是必要的,而这也是一些研究较少的胃肠道(GI)疾病的病因。

目的

本研究旨在通过采用生物磁技术,调查三联免疫抑制治疗对肾移植患者胃肠道转运的影响。

方法

21例肾移植患者接受三联治疗,该治疗包括他克莫司(TAC)或环孢素A(CsA)联合泼尼松和硫唑嘌呤。对他们全部进行了评估,另外15名健康个体组成对照组。在摄入标准化餐后,使用交流电生物磁测量法(ACB)评估磁性标记物的胃肠道转运情况。

结果

与服用CsA的患者和对照组相比,服用TAC的患者胃排空和结肠到达时间显著加快(p≤0.001)。然而,在所研究的各组之间小肠转运方面未观察到差异。总体而言,TAC组胃肠道转运参数的个体间变异系数较高,CsA组和对照组相似。

结论

本研究表明,在评估不同免疫抑制治疗对肾移植后胃肠道转运的影响时,ACB是一种合适的方法。在用他克莫司治疗的患者中发现了明显的个体间差异,从而显示了该药物对胃肠动力的促动力作用。对该人群的动力模式进行研究,可能有助于作为补充信息来确定机制以及动力与治疗剂量之间的关系。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验